Prostaglandin D2 Receptor DP1 Antibodies Predict Vaccine-induced and Spontaneous Narcolepsy Type 1: Large-scale Study of Antibody Profiling
暂无分享,去创建一个
J. Vilo | M. Partinen | T. Neuman | A. Vaheri | O. Vapalahti | K. Palm | Priit Adler | H. Sadam | A. Pihlak | Susan Pihelgas | Anri Kivil | D. Lindholm | M. Jaago | P. Adler
[1] E. Mignot,et al. Autoimmunity in narcolepsy , 2017, Current opinion in pulmonary medicine.
[2] Shuvomoy Banerjee,et al. An essential EBV latent antigen 3C binds Bcl6 for targeted degradation and cell proliferation , 2017, PLoS pathogens.
[3] M. Partinen,et al. Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. , 2017, Sleep medicine reviews.
[4] S. Perlman,et al. Virus-induced inflammasome activation is suppressed by prostaglandin D2/DP1 signaling , 2017, Proceedings of the National Academy of Sciences.
[5] S. Butcher,et al. Human picornaviruses associated with neurological diseases and their neutralization by antibodies. , 2017, The Journal of general virology.
[6] Y. Urade,et al. Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2 , 2017, PloS one.
[7] T. Olsson,et al. The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene–environment interaction , 2017, Genes and Immunity.
[8] Peter Nilsson,et al. Whole-Proteome Peptide Microarrays for Profiling Autoantibody Repertoires within Multiple Sclerosis and Narcolepsy. , 2017, Journal of proteome research.
[9] M. Partinen,et al. Transient Impact of Rituximab in H1N1 Vaccination–associated Narcolepsy With Severe Psychiatric Symptoms , 2016, The neurologist.
[10] D. Radovanovic,et al. Prostaglandin D2 receptor antagonists in early development as potential therapeutic options for asthma , 2016, Expert opinion on investigational drugs.
[11] Björn Forsström,et al. Autoantibody targets in vaccine-associated narcolepsy , 2016, Autoimmunity.
[12] P. Montuschi,et al. Investigational prostaglandin D2 receptor antagonists for airway inflammation , 2016, Expert opinion on investigational drugs.
[13] Peter Nilsson,et al. Antigen arrays for profiling autoantibody repertoires. , 2016, Bioanalysis.
[14] W. Brück,et al. Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen , 2016, Acta Neuropathologica.
[15] Chien-Hsun Wu,et al. Advancement and applications of peptide phage display technology in biomedical science , 2016, Journal of Biomedical Science.
[16] M. Tafti,et al. Comment on “Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2” , 2015, Science Translational Medicine.
[17] Morten Nielsen,et al. High-throughput sequencing enhanced phage display enables the identification of patient-specific epitope motifs in serum , 2015, Scientific Reports.
[18] E. Mignot,et al. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development , 2015, Brain, Behavior, and Immunity.
[19] R. Rappuoli,et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 , 2015, Science Translational Medicine.
[20] J. Scolnick. Faculty Opinions recommendation of Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. , 2015 .
[21] S. Elledge,et al. Comprehensive serological profiling of human populations using a synthetic human virome , 2015, Science.
[22] A. Régnault,et al. Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ? , 2015, Journal of autoimmunity.
[23] M. Partinen,et al. Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk , 2014, PloS one.
[24] Deborah Hix,et al. The immune epitope database (IEDB) 3.0 , 2014, Nucleic Acids Res..
[25] T. Strom,et al. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. , 2014, Sleep.
[26] T. Hökfelt,et al. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns , 2014, Proceedings of the National Academy of Sciences.
[27] G. Plazzi,et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination , 2014, The Lancet Neurology.
[28] Å. Lernmark,et al. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010. , 2014, Journal of autoimmunity.
[29] P. Schur,et al. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. , 2014, Journal of autoimmunity.
[30] Gioele La Manno,et al. Quantitative single-cell RNA-seq with unique molecular identifiers , 2013, Nature Methods.
[31] Mark M. Davis,et al. CD4+ T Cell Autoimmunity to Hypocretin/Orexin and Cross-Reactivity to a 2009 H1N1 Influenza A Epitope in Narcolepsy , 2013, Science Translational Medicine.
[32] J. Siegel,et al. Greatly increased numbers of histamine cells in human narcolepsy with cataplexy , 2013, Annals of neurology.
[33] E. Mignot,et al. Increase of histaminergic tuberomammillary neurons in narcolepsy , 2013, Annals of neurology.
[34] H. Sei,et al. Histamine from Brain Resident MAST Cells Promotes Wakefulness and Modulates Behavioral States , 2013, PloS one.
[35] J. Chapman,et al. Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. , 2013, Journal of autoimmunity.
[36] M. Gelb,et al. Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2–DP1 receptor paracrine axis , 2013, Nature Immunology.
[37] E. Mignot,et al. Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic , 2013, Annals of neurology.
[38] T. Neuman,et al. CCL5/CCR1 axis regulates multipotency of human adipose tissue derived stromal cells. , 2013, Stem cell research.
[39] T. Kolter. Ganglioside Biochemistry , 2012, ISRN biochemistry.
[40] S. Gammeltoft,et al. Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency , 2012, Neurology.
[41] J. Matés,et al. Mammalian Glutaminase Gls2 Gene Encodes Two Functional Alternative Transcripts by a Surrogate Promoter Usage Mechanism , 2012, PloS one.
[42] O. Engelhardt,et al. An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs. , 2012, Vaccine.
[43] Y. Urade,et al. Prostaglandin D2 and sleep/wake regulation. , 2011, Sleep medicine reviews.
[44] E. Mignot,et al. Narcolepsy with Hypocretin/orexin Deficiency, Infections and Autoimmunity of the Brain This Review Comes from a Themed Issue on Neurobiology of Disease Edited Narcolepsy with Hypocretin Deficiency , 2022 .
[45] E. Mignot,et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china , 2011, Annals of neurology.
[46] M. Schlüter,et al. Antibody Response After a Single Dose of an AS03-Adjuvanted Split-Virion Influenza A (H1N1) Vaccine in Heart Transplant Recipients , 2011, Transplantation.
[47] Garret A. FitzGerald,et al. Prostaglandins and Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[48] Anne S De Groot,et al. Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus. , 2011, Vaccine.
[49] P. Chomez,et al. Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity. , 2011, Vaccine.
[50] P. Philibert,et al. Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology , 2011, Journal of ovarian research.
[51] C. Davis,et al. The development of vaccine viruses against pandemic A(H1N1) influenza. , 2011, Vaccine.
[52] T. Neuman,et al. Human dermal fibroblasts exhibit delayed adipogenic differentiation compared with mesenchymal stem cells. , 2011, Stem cells and development.
[53] J. Schwartz,et al. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin , 2010, Journal of sleep research.
[54] J. Arístegui,et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. , 2010, Vaccine.
[55] Yurij Ionov,et al. A high throughput method for identifying personalized tumor-associated antigens , 2010, Oncotarget.
[56] M. Mühlethaler,et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. , 2010, The Journal of clinical investigation.
[57] T. Koepsell,et al. Narcolepsy and streptococcal infections. , 2009, Sleep.
[58] J. Siegel,et al. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. , 2009, Sleep.
[59] E. Mignot,et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. , 2009, Sleep.
[60] C. Gieger,et al. Narcolepsy is strongly associated with the TCR alpha locus , 2009, Nature Genetics.
[61] E. Mignot,et al. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. , 2009, Sleep.
[62] D. Crossman,et al. Tribbles-2 is a novel regulator of inflammatory activation of monocytes , 2008, International immunology.
[63] Arthur Christopoulos,et al. Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands* , 2007, Journal of Biological Chemistry.
[64] T. Kudo,et al. Hematopoietic Prostaglandin D Synthase and DP1 Receptor Are Selectively Upregulated in Microglia and Astrocytes Within Senile Plaques From Human Patients and in a Mouse Model of Alzheimer Disease , 2007, Journal of neuropathology and experimental neurology.
[65] S. Narumiya,et al. Prostaglandin D2-Mediated Microglia/Astrocyte Interaction Enhances Astrogliosis and Demyelination in twitcher , 2006, The Journal of Neuroscience.
[66] E. Kiss-Toth,et al. Regulation of expression and signalling modulator function of mammalian tribbles is cell-type specific. , 2006, Immunology letters.
[67] Alun Williams,et al. Prostaglandin D2 mediates neuronal damage by amyloid-β or prions which activates microglial cells , 2006, Neuropharmacology.
[68] V. Turygin,et al. Characteristics of Mast Cells in the Choroid Plexus of the Ventricles of the Human Brain in Aging , 2005, Neuroscience and Behavioral Physiology.
[69] T. Hand,et al. Prostaglandin D2 mediates neuronal protection via the DP1 receptor , 2005, Journal of neurochemistry.
[70] Michael W. Jackson,et al. A functional autoantibody in narcolepsy , 2004, The Lancet.
[71] B. Heyman,et al. IgG2a-Mediated Enhancement of Antibody and T Cell Responses and Its Relation to Inhibitory and Activating Fcγ Receptors1 , 2004, The Journal of Immunology.
[72] R. De Caro,et al. The distribution of mast cells in the human area postrema , 2004, Journal of anatomy.
[73] J. Siegel,et al. Pattern of Hypocretin (Orexin) Soma and Axon Loss, and Gliosis, in Human Narcolepsy , 2003, Brain pathology.
[74] P. Murdock,et al. Mammalian class Sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. , 2001, The Biochemical journal.
[75] G. FitzGerald,et al. Genetic and pharmacological analysis of prostanoid receptor function. , 2001, The Journal of clinical investigation.
[76] T. Kaneko,et al. Cellular localization of lipocalin‐type prostaglandin D synthase (β‐trace) in the central nervous system of the adult rat , 2000, The Journal of comparative neurology.
[77] Sebastiaan Overeem,et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains , 2000, Nature Medicine.
[78] Michael Aldrich,et al. Reduced Number of Hypocretin Neurons in Human Narcolepsy , 2000, Neuron.
[79] C Oseroff,et al. Human memory CTL response specific for influenza A virus is broad and multispecific. , 2000, Human immunology.
[80] I. Jonassen,et al. Predicting gene regulatory elements in silico on a genomic scale. , 1998, Genome research.
[81] M. Saito,et al. Interleukin-1 Induces Slow-Wave Sleep at the Prostaglandin D2-Sensitive Sleep-Promoting Zone in the Rat Brain , 1998, The Journal of Neuroscience.
[82] Esko Ukkonen,et al. Pattern Discovery in Biosequences , 1998, ICGI.
[83] A. Viale,et al. The melanin-concentrating hormone gene in human: flanking region analysis, fine chromosome mapping, and tissue-specific expression. , 1997, Brain research. Molecular brain research.
[84] Z. Kutalik,et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. , 2014, Sleep.
[85] Christian Gieger,et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus (vol 41, pg 708, 2009) , 2014 .
[86] M. Alcaraz,et al. Prostaglandin D2 regulates joint inflammation and destruction in murine collagen-induced arthritis. , 2012, Arthritis and rheumatism.
[87] S. Nishino. Hypothalamus, hypocretins/orexin, and vigilance control. , 2011, Handbook of clinical neurology.
[88] T. Voisin,et al. Orexins and their receptors: structural aspects and role in peripheral tissues , 2003, Cellular and Molecular Life Sciences CMLS.
[89] Econor,et al. ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS , 2002 .
[90] B. Mitchell,et al. Human Cytosolic 5 * -Nucleotidase I CHARACTERIZATION AND ROLE IN NUCLEOSIDE ANALOG RESISTANCE* , 2001 .
[91] Michael Gribskov,et al. Combining evidence using p-values: application to sequence homology searches , 1998, Bioinform..
[92] M. Suyama,et al. Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. , 1998, DNA research : an international journal for rapid publication of reports on genes and genomes.
[93] Charles Elkan,et al. Fitting a Mixture Model By Expectation Maximization To Discover Motifs In Biopolymer , 1994, ISMB.